Editorial: Unravelling the role of CB2r in neuropsychiatric diseases.
作者信息
Onaivi Emmanuel S
机构信息
Department of Biology, College of Science and Health, William Paterson University, Wayne, NJ, United States.
出版信息
Front Psychiatry. 2023 Mar 20;14:1171959. doi: 10.3389/fpsyt.2023.1171959. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Unravelling the role of CB2r in neuropsychiatric diseases.
Front Psychiatry. 2023 Mar 20;14:1171959. doi: 10.3389/fpsyt.2023.1171959. eCollection 2023.
2
Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders.
Front Psychiatry. 2022 Jun 14;13:828895. doi: 10.3389/fpsyt.2022.828895. eCollection 2022.
3
Pharmacological potential of JWH133, a cannabinoid type 2 receptor agonist in neurodegenerative, neurodevelopmental and neuropsychiatric diseases.
Eur J Pharmacol. 2021 Oct 15;909:174398. doi: 10.1016/j.ejphar.2021.174398. Epub 2021 Jul 29.
4
The endocannabinoidome in neuropsychiatry: Opportunities and potential risks.
Pharmacol Res. 2021 Aug;170:105729. doi: 10.1016/j.phrs.2021.105729. Epub 2021 Jun 11.
5
Perspectives of Cannabinoid Type 2 Receptor (CB2R) Ligands in Neurodegenerative Disorders: Structure-Affinity Relationship (SAfiR) and Structure-Activity Relationship (SAR) Studies.
J Med Chem. 2017 Dec 28;60(24):9913-9931. doi: 10.1021/acs.jmedchem.7b00155. Epub 2017 Jun 30.
6
Immunomodulatory Role of CB2 Receptors in Emotional and Cognitive Disorders.
Front Psychiatry. 2022 Apr 15;13:866052. doi: 10.3389/fpsyt.2022.866052. eCollection 2022.
7
In vivo inflammation imaging using a CB2R-targeted near infrared fluorescent probe.
Am J Nucl Med Mol Imaging. 2015 Feb 15;5(3):246-58. eCollection 2015.
8
Targeted zwitterionic near infrared fluorescent probe for improved imaging of type 2 cannabinoid receptors.
J Biomed Opt. 2014 Mar;19(3):36006. doi: 10.1117/1.JBO.19.3.036006.
9
Beta-caryophyllene alleviates diet-induced neurobehavioral changes in rats: The role of CB2 and PPAR-γ receptors.
Biomed Pharmacother. 2019 Feb;110:145-154. doi: 10.1016/j.biopha.2018.11.039. Epub 2018 Nov 20.
10
The CB2 cannabinoid receptor as a therapeutic target in the central nervous system.
Expert Opin Ther Targets. 2021 Aug;25(8):659-676. doi: 10.1080/14728222.2021.1971196. Epub 2021 Sep 23.
引用本文的文献
1
CB2 expression in mouse brain: from mapping to regulation in microglia under inflammatory conditions.
J Neuroinflammation. 2024 Aug 19;21(1):206. doi: 10.1186/s12974-024-03202-8.
本文引用的文献
1
Editorial: Targeting the endocannabinoidome in neurodegenerative disorders.
Front Aging Neurosci. 2023 Jan 4;14:1116635. doi: 10.3389/fnagi.2022.1116635. eCollection 2022.
2
A PLS study on the psychotropic activity for a series of cannabinoid compounds.
J Mol Model. 2023 Jan 19;29(2):46. doi: 10.1007/s00894-023-05443-5.
3
Update on the controversial identity of cells expressing cnr2 gene in the nervous system.
CNS Neurosci Ther. 2023 Mar;29(3):760-770. doi: 10.1111/cns.13977. Epub 2023 Jan 5.
4
CB2 Receptor in Microglia: The Guardian of Self-Control.
Int J Mol Sci. 2020 Dec 22;22(1):19. doi: 10.3390/ijms22010019.
5
Cannabinoids and the expanded endocannabinoid system in neurological disorders.
Nat Rev Neurol. 2020 Jan;16(1):9-29. doi: 10.1038/s41582-019-0284-z. Epub 2019 Dec 12.
6
Endocannabinoid System Components: Overview and Tissue Distribution.
Adv Exp Med Biol. 2019;1162:1-12. doi: 10.1007/978-3-030-21737-2_1.
7
Cannabis, cannabinoid receptors, and endocannabinoid system: yesterday, today, and tomorrow.
Acta Pharmacol Sin. 2019 Mar;40(3):297-299. doi: 10.1038/s41401-019-0210-3. Epub 2019 Jan 22.
8
Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons.
Behav Brain Res. 2019 Mar 15;360:286-297. doi: 10.1016/j.bbr.2018.11.043. Epub 2018 Nov 30.
9
CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity.
J Psychopharmacol. 2012 Jan;26(1):92-103. doi: 10.1177/0269881111400652. Epub 2011 Mar 29.
Zotero 插件